Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.

Francis, Sebastian; Thomas, Sally; Luben, Robert; Sousos, Nikolaos; Mead, Adam; Snowden, John A; Zeidler, Martin P

Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.

Francis, Sebastian;Thomas, Sally;Luben, Robert;Sousos, Nikolaos;Mead, Adam;Snowden, John A;Zeidler, Martin P;

British journal of haematology 2019

281

francis2019lowdosebritish

Keywords

inflammation symptoms methotrexate mpn10 myeloproliferative neoplasms

Access

DOI:

10.1111/bjh.16193

Citation

ID: 45603

Ref Key: francis2019lowdosebritish

Use this key to autocite in SciMatic or Thesis Manager

References

No Bibliography

Blockchain Verification

Account:

NFT Contract Address:

0x95644003c57E6F55A65596E3D9Eac6813e3566dA

Article ID:

45603

Unique Identifier:

10.1111/bjh.16193

Network:

Scimatic Chain (ID: 481)

Blockchain Readiness Checklist

Authors

Abstract

Journal Name

Year

Title

4/5

Blockchain Upload Locked

Complete all 5 checklist items to tokenize your article

Gas fees required in SCI Coins

Buy SCI

Saymatik Web3.0 Wallet

Google Play

App Store

Low-dose methotrexate: potential clinical impact on haematological and constitutional symptoms in myeloproliferative neoplasms.

Keywords

Access

Citation

References

References

Blockchain Verification

Blockchain Readiness Checklist

Saymatik Web3.0 Wallet

About

Services

Legal

License